| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q3 2018 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CME GROUP INC COM | 6 | Q3 2014 | 100.0% |
| ISHARES TR INDEX PUT | 3 | Q1 2014 | 15.9% |
| ISHARES SILVER TRUST ISHARES | 3 | Q4 2013 | 13.2% |
| BARRICK GOLD CORP COM | 3 | Q4 2013 | 4.2% |
| SPDR S&P 500 ETF TR | 2 | Q2 2014 | 23.6% |
| SPDR S&P 500 ETF TR | 2 | Q2 2014 | 23.6% |
| SELECT SECTOR SPDR TR CALL | 2 | Q2 2014 | 21.9% |
| SILVER WHEATON CORP COM | 2 | Q4 2013 | 15.9% |
| SELECT SECTOR SPDR TR PUT | 2 | Q2 2014 | 8.5% |
| HALLIBURTON CO CALL | 2 | Q4 2013 | 5.1% |
View Vermillion Asset Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| REPROS THERAPEUTICS INC.Sold out | May 04, 2009 | 0 | 0.0% |
| Cardiome Pharma Corp | February 17, 2009 | 4,011,600 | 6.3% |
View Vermillion Asset Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2014-11-03 |
| 13F-HR | 2014-08-12 |
| 13F-HR | 2014-05-07 |
| 13F-HR/A | 2014-02-14 |
| 13F-HR | 2014-02-14 |
| 13F-HR | 2013-11-13 |
| 13F-HR | 2013-07-16 |
| 13F-HR | 2013-04-26 |
| 13F-HR | 2013-02-13 |
| 13F-HR | 2012-11-13 |
View Vermillion Asset Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.